VALERIE GOODWIN: Open Payments
NPI 1154829257 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,117 in 79 payments from 22 companies in 2025. Trend: 2023 $3,880 · 2024 $3,544 · 2025 $5,117
Travel & lodging: $3,541Food & beverage: $1,576
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $3,786 |
| Novo Nordisk Inc | 7 | $219 |
| Lilly USA, LLC | 11 | $167 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $161 |
| PFIZER INC. | 5 | $113 |
| Amgen Inc. | 5 | $91 |
| Exact Sciences Corporation | 4 | $70 |
| Corcept Therapeutics | 3 | $66 |
| Antares Pharma, Inc. | 3 | $63 |
| Boston Scientific Corporation | 3 | $62 |
Products named: Kerendia, Ozempic, MOUNJARO, ELIQUIS, REPATHA, Cologuard Collection Kit, JARDIANCE, Korlym.
Industry payments across AL — which companies pay providers there.
